131 related articles for article (PubMed ID: 8650693)
1. Dose-dependent reversal of digoxin-inhibited activity of an in vitro Na+K+ATPase model by digoxin-specific antibody.
Cano NJ; Sabouraud AE; Debray M; Scherrmann JM
Toxicol Lett; 1996 May; 85(2):107-11. PubMed ID: 8650693
[TBL] [Abstract][Full Text] [Related]
2. Affinity and dose-dependent digoxin Na+K+ATPase dissociation by monoclonal digoxin-specific antibodies.
Cano NJ; Navarro-Teulon I; Debray M; Piechaczyk M; Scherrmann JM
Biochem Pharmacol; 1995 Nov; 50(11):1867-72. PubMed ID: 8615866
[TBL] [Abstract][Full Text] [Related]
3. The influence of potassium ion (K+) on digoxin-induced inhibition of porcine cerebral cortex Na+ / K+-ATPase.
Krstić D; Tomić N; Krinulović K; Vasić V
J Enzyme Inhib Med Chem; 2006 Aug; 21(4):471-5. PubMed ID: 17059183
[TBL] [Abstract][Full Text] [Related]
4. Reversal of toxic and non-toxic effects of digoxin by digoxin-specific Fab fragments in isolated human ventricular myocardium.
Näbauer M; Erdmann E
Klin Wochenschr; 1987 Jul; 65(12):558-61. PubMed ID: 3041099
[TBL] [Abstract][Full Text] [Related]
5. Enhanced clearance of specifically bound digoxin from human myocardial and skeletal muscle samples by specific digoxin antibody fragments: subsequent complete digitalis glycoside receptor (Na,K-ATPase) quantification.
Schmidt TA; Kjeldsen K
J Cardiovasc Pharmacol; 1991 Apr; 17(4):670-7. PubMed ID: 1711637
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids.
Pullen MA; Brooks DP; Edwards RM
J Pharmacol Exp Ther; 2004 Jul; 310(1):319-25. PubMed ID: 14982968
[TBL] [Abstract][Full Text] [Related]
7. Effects of digoxin and gitoxin on the enzymatic activity and kinetic parameters of Na+/K+-ATPase.
Krstić D; Krinulović K; Spasojević-Tisma V; Joksić G; Momić T; Vasić V
J Enzyme Inhib Med Chem; 2004 Oct; 19(5):409-15. PubMed ID: 15648655
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of erythrocyte and renal Na+,K+-adenosine triphosphatase activity by antidigoxin antibody in normal rats.
Wagener OE; Mujais SK; Del Greco F; Quintanilla AP
Clin Sci (Lond); 1989 Dec; 77(6):617-21. PubMed ID: 2558000
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
Fedorova OV; Simbirtsev AS; Kolodkin NI; Kotov AY; Agalakova NI; Kashkin VA; Tapilskaya NI; Bzhelyansky A; Reznik VA; Frolova EV; Nikitina ER; Budny GV; Longo DL; Lakatta EG; Bagrov AY
J Hypertens; 2008 Dec; 26(12):2414-25. PubMed ID: 19008721
[TBL] [Abstract][Full Text] [Related]
10. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
Oselkin M; Tian D; Bergold PJ
Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the affinities of rat (Na+ + K+)-ATPase isozymes for cardioactive steroids, role of lactone ring, sugar moiety and KCl concentration.
Noël F; Fagoo M; Godfraind T
Biochem Pharmacol; 1990 Dec; 40(12):2611-6. PubMed ID: 2175607
[TBL] [Abstract][Full Text] [Related]
12. Brain Na+,K+-ATPase isozyme activity and protein expression in ouabain-induced hypertension.
Kent MA; Huang BS; Van Huysse JW; Leenen FH
Brain Res; 2004 Aug; 1018(2):171-80. PubMed ID: 15276875
[TBL] [Abstract][Full Text] [Related]
13. Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K(+)-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats.
Bagrov AY; Fedorova OV; Roukoyatkina NI; Zhabko EP
Cardiovasc Res; 1993 Jun; 27(6):1045-50. PubMed ID: 8221762
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of Na+ pump alpha 2 isoform in isoprenaline-induced cardiac hypertrophy in rat: evidence for increased receptor binding affinity but reduced inotropic potency of digoxin.
Baek M; Weiss M
J Pharmacol Exp Ther; 2005 May; 313(2):731-9. PubMed ID: 15644428
[TBL] [Abstract][Full Text] [Related]
15. Specificity of the volume-sensitive sodium pump inhibitor isolated from human peritoneal dialysate in chronic renal failure.
Tao QF; Soszynski PA; Hollenberg NK; Graves SW
Kidney Int; 1996 Feb; 49(2):420-9. PubMed ID: 8821826
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
17. The chronic effects of long-term digoxin administration on Na+/K(+)-ATPase activity in rat tissues.
Li PW; Ho CS; Swaminathan R
Int J Cardiol; 1993 Jul; 40(2):95-100. PubMed ID: 8394287
[TBL] [Abstract][Full Text] [Related]
18. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
[TBL] [Abstract][Full Text] [Related]
19. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
Chan BS; Buckley NA
Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of membrane Na(+)-K+ Atpase of the brain, liver and RBC in rats administered di(2-ethyl hexyl) phthalate (DEHP) a plasticizer used in polyvinyl chloride (PVC) blood storage bags.
Dhanya CR; Indu AR; Deepadevi KV; Kurup PA
Indian J Exp Biol; 2003 Aug; 41(8):814-20. PubMed ID: 15248477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
